Director · Sionna Therapeutics, Inc. · Sionna Therapeutics, Inc. — Non-Qualified Stock Option (right to buy)
Side
A
Value
—
Shares
17.3K
Price
—
Executed
Jun 17, 2026
Disclosed
Jun 18, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Jun 17 executedJun 18, 2026 disclosed
SION · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Sionna Therapeutics, Inc. — Non-Qualified Stock Option (right to buy)
Ticker
SION
Shares
17.3K
Price per share
$0
Execution date (reported)
Jun 17, 2026
Owned after transaction
17.3K shares
Days from execution to publication
1
What this establishes
Fleming Harold Edward filed this Form 4 reporting a grant or award of SION on Jun 17, 2026. It became public on Jun 18, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Fleming Harold Edwardcik:0001857250
Issuer
Sionna Therapeutics, Inc.cik:0002036042
Revision history · 0
No field has changed since this record was first ingested.
